The blood cancer drugs market is a rapidly evolving sector within the broader therapeutic landscape, fueled by significant technological advancements and an alarming rise in disease prevalence. This marketplace is experiencing robust growth due to a convergence of factors, including breakthroughs in research and development, an aging global population, increased awareness of blood cancers, and...